Analyst Price Targets — ICLR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 23, 2026 9:40 am | David Windley | Jefferies | $135.00 | $99.70 | TheFly | Icon upgraded to Buy from Hold at Jefferies |
| February 17, 2026 9:58 am | Jamie Clark | Redburn Partners | $100.00 | $93.00 | TheFly | Icon downgraded to Neutral from Buy at Rothschild & Co Redburn |
| February 13, 2026 2:21 pm | — | Robert W. Baird | $119.00 | $91.63 | TheFly | Icon price target lowered to $119 from $217 at Baird |
| February 12, 2026 1:58 pm | Sean Dodge | BMO Capital | $100.00 | $84.63 | TheFly | Icon price target lowered to $100 from $175 at BMO Capital |
| February 12, 2026 1:25 pm | Michael Cherny | Leerink Partners | $105.00 | $83.90 | TheFly | Icon downgraded to Market Perform from Outperform at Leerink |
| January 9, 2026 1:33 pm | — | Robert W. Baird | $217.00 | $187.66 | TheFly | Icon price target lowered to $217 from $220 at Baird |
| January 9, 2026 12:09 pm | — | Mizuho Securities | $216.00 | $188.22 | TheFly | Icon price target lowered to $216 from $225 at Mizuho |
| January 8, 2026 10:14 am | — | Truist Financial | $222.00 | $202.92 | TheFly | Icon downgraded to Hold from Buy at Truist |
| December 15, 2025 10:54 am | Luke Sergott | Barclays | $200.00 | $186.71 | TheFly | Icon price target raised to $200 from $185 at Barclays |
| October 24, 2025 12:13 pm | — | UBS | $220.00 | $175.87 | TheFly | Icon price target lowered to $220 from $240 at UBS |
Latest News for ICLR
On April 15, 2026, Icon PLC (ICLR) shares experienced a positive movement, rising 3.0% to a current price of $116.50. This recent uptick comes amidst a 52-week
Artisan Mid Cap Value Fund portfolio trailed the Russell Midcap® Value Index in Q1. Performance was weighed down by a market environment that continued to favor momentum-driven stocks, with less support for quality factors. Among the biggest decliners were ICON, Gartner and Pinterest, each of which dropped by 30% or more during the quarter. Our three largest new buys by position size were Brown & Brown, Veralto and…
Icon (NASDAQ: ICLR - Get Free Report) and Aeon Global Health (OTCMKTS:AGHC - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations. Profitability This table compares Icon and Aeon Global
Eldred Rock Partners LLC lessened its holdings in shares of Icon Plc (NASDAQ: ICLR) by 10.1% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,071 shares of the medical research company's stock after selling 5,946 shares during the period. Icon
Allspring Global Investments Holdings LLC grew its stake in Icon Plc (NASDAQ: ICLR) by 1.1% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 1,080,192 shares of the medical research company's stock after buying an additional 11,335 shares during the quarter. Allspring Global Investments Holdings LLC
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ICLR.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.